News

The purpose of the study was to evaluate the potential additive effect of treating erectile dysfunction (ED) patients with both PT-141, which initiates erections via a central nervous

The randomized, controlled clinical trial, which has enrolled more than 460 patients in Europe, Australia and Canada, is evaluating best supportive care plus panitumumab monotherapy administered every other

The researchers found that a fragment of collagen VII is required for the skin cancer cells to break free from the neighboring skin tissue and spread – a

The Medicines and Healthcare products Regulatory Agency (MHRA) aims to ensure that medicines, healthcare products and medical equipment meet appropriate standards of safety, quality, performance and effectiveness. It

The multi-center, open label, phase IIb study is being conducted by Cancer Trials Australia at three institutions, including Melbourne’s Austin Health, Royal Melbourne Hospital and the Peter MacCallum

The phase I dose escalation study treated 22 patients with advanced solid tumors. All patients had previously been treated for cancer, and the majority had received surgery in

The anti-CD55 antibody is under an exclusive option from Cancer Research Technology (UK), and is being developed for the treatment of a broad range of solid tumors. These

The FDA licensed Menactra vaccine in January for use among 11 through 55 year olds. Sanofi Pasteur has now filed a supplemental application with the FDA to amend

Following recent regulatory setbacks for Marqibo (vincristine sulfate liposomes injection), and after a careful evaluation, Enzon determined it will not support further development of the product. In January